Stifel Upgrades Treace Medical Concepts to Buy, Raises Price Target to $6.5
Benzinga Newsdesk 21 hours ago
Analyst RatingsNewsUpgradesPrice Target
Stifel analyst Rick Wise upgrades Treace Medical Concepts (NASDAQ:TMCI) from Hold to Buy and raises the price target from $4.5 to $6.5.
Stifel analyst Rick Wise upgrades Treace Medical Concepts (NASDAQ:TMCI) from Hold to Buy and raises the price target from $4.5 to $6.5.